Literature DB >> 23408017

Efficacy of osteoporosis therapies in a network meta-analysis with indirect comparisons: many concerns for new tools of evidence synthesis?

F Catalá-López, G Sanfélix-Gimeno, A Tobías, I Hurtado, J Sanfélix-Genovés, S Peiró.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23408017     DOI： 10.1007/s00198-013-2294-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  4 in total

1.  Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool.

Authors:  Georgia Salanti
Journal:  Res Synth Methods       Date:  2012-06-11       Impact factor: 5.273

2.  [Clinical evidence synthesis and network meta-analysis with indirect-treatment comparisons].

Authors:  Ferrán Catalá-López; Aurelio Tobías
Journal:  Med Clin (Barc)       Date:  2012-11-21       Impact factor: 1.725

3.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Javier San Martin; Michael R McClung; Ethel S Siris; Richard Eastell; Ian R Reid; Pierre Delmas; Holly B Zoog; Matt Austin; Andrea Wang; Stepan Kutilek; Silvano Adami; Jose Zanchetta; Cesar Libanati; Suresh Siddhanti; Claus Christiansen
Journal:  N Engl J Med       Date:  2009-08-11       Impact factor: 91.245

4.  Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Authors:  N Freemantle; C Cooper; A Diez-Perez; M Gitlin; H Radcliffe; S Shepherd; C Roux
Journal:  Osteoporos Int       Date:  2012-07-26       Impact factor: 4.507
  4 in total
  2 in total

1.  Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

Authors:  M Tadrous; L Wong; M M Mamdani; D N Juurlink; M D Krahn; L E Lévesque; S M Cadarette
Journal:  Osteoporos Int       Date:  2013-11-28       Impact factor: 4.507

2.  A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects.

Authors:  L Wei; J Ke; I Prasadam; R J Miron; S Lin; Y Xiao; J Chang; C Wu; Y Zhang
Journal:  Osteoporos Int       Date:  2014-05-08       Impact factor: 4.507
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.